Neuropsychiatric aspects of HIV infection and AIDS

dc.authorscopusid6603321948
dc.contributor.authorYi?it, Enize Arzu
dc.date.accessioned2024-09-19T15:49:49Z
dc.date.available2024-09-19T15:49:49Z
dc.date.issued2004
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractAcquired immune deficiency syndrome (AIDS) is a lethal neuromedical disorder associated with infection by viruses of the Retroviridae class know as human immunodeficiency viruses (HIV). Medical and neuropsychiatric sequelae of HIV infection present a spectrum of diagnostic and treatment challenges to mental health clinicians. These sequelae can result in new onset psychiatric conditions in persons with no premorbid history of severe mental illness, and can complicate the clinical picture in persons with a history of severe mental illness prior to HIV infection. HIV enters the centra nervous system soon after infection, and result in clinical manifestations that may range from neurocognitive impairment to dementia. In this article, some of the more common neuropsychiatric manifestations of HIV infection (HIV-related dementia, now onset psychosis, mood disorders, anxiety, delirium) and general treatment strategies are described.en_US
dc.identifier.endpage56en_US
dc.identifier.issn1016-5134
dc.identifier.issue5en_US
dc.identifier.scopus2-s2.0-2942740840en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage51en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12483/15431
dc.identifier.volume16en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.relation.ispartofSENDROMen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectantiretrovirus agenten_US
dc.subjectbenzodiazepine derivativeen_US
dc.subjectcarbamazepineen_US
dc.subjectchlorpromazineen_US
dc.subjectcitalopramen_US
dc.subjectdesipramineen_US
dc.subjectdiazepamen_US
dc.subjectfluoxetineen_US
dc.subjecthaloperidolen_US
dc.subjectlithiumen_US
dc.subjectlorazepamen_US
dc.subjectmethylphenidateen_US
dc.subjectneuroleptic agenten_US
dc.subjectnortriptylineen_US
dc.subjectolanzapineen_US
dc.subjectparoxetineen_US
dc.subjectproteinase inhibitoren_US
dc.subjectrisperidoneen_US
dc.subjectserotonin uptake inhibitoren_US
dc.subjectsertralineen_US
dc.subjecttricyclic antidepressant agenten_US
dc.subjectvalproic aciden_US
dc.subjectvenlafaxineen_US
dc.subjectzidovudineen_US
dc.subjectacquired immune deficiency syndromeen_US
dc.subjectanxiety disorderen_US
dc.subjectcentral nervous systemen_US
dc.subjectclinical featureen_US
dc.subjectcognitive defecten_US
dc.subjectdeliriumen_US
dc.subjectdementiaen_US
dc.subjectdisease associationen_US
dc.subjectdisease severityen_US
dc.subjectextrapyramidal symptomen_US
dc.subjecthumanen_US
dc.subjectHuman immunodeficiency virus infectionen_US
dc.subjectlethalityen_US
dc.subjectmajor depressionen_US
dc.subjectmental healthen_US
dc.subjectmood disorderen_US
dc.subjectneuropsychiatryen_US
dc.subjectpsychosisen_US
dc.subjectpsychotherapyen_US
dc.subjectRetrovirusen_US
dc.subjectreviewen_US
dc.titleNeuropsychiatric aspects of HIV infection and AIDSen_US
dc.title.alternativeHIV infeksiyonu ve AIDS'in nöropsikiyatrik yönlerien_US
dc.typeReview Articleen_US

Dosyalar